HPGC Renmintongtai Pharmaceutical Corp operates in the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares HPGC Renmintongtai Pharmaceutical Corp with three other
drug stores in Asia:
Qol Co Ltd
sales of 124.96 billion Japanese Yen [US$1.11 billion]
of which 92%
was Pharmacy Business Insurance),
Kusuri No Aoki Holdings Co Ltd
(163.46 billion Japanese Yen [US$1.45 billion]
Sogo Medical Company Limited
based in Japan
(120.78 billion Japanese Yen [US$1.07 billion]
of which 36%
was Operating segment-Eastern Japan).
HPGC Renmintongtai Pharmaceutical Corp reported sales of 9.01 billion Chinese Renmimbi (US$1.30 billion)
December of 2016.
a very small
increase of 1.1%
versus 2015, when the company's sales were 8.91 billion Chinese Renmimbi.
Sales of Other Operation saw an increase
that was more than double the company's growth rate: sales were up
12.4% in 2016, from
20.62 million Chinese Renmimbi to 23.17 million Chinese Renmimbi.
HPGC Renmintongtai Pharmaceutical Corp also saw significant increases in sales in
Other (up 10.3% to 81.48 million Chinese Renmimbi)